跳至主要内容
临床试验/NCT01955044
NCT01955044已完成不适用

Early DHA Supplementation in Extremely Low Birth Weight Infants

Endeavor Health6 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2013年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
6
主要终点
Long-chain Polyunsaturated Fatty Acid (LCPUFA) Levels

研究概览

简要总结

The purpose of this study is to determine if buccal administration of a concentrated formulation of long-chain polyunsaturated fatty acids (LCPUFA) can help to maintain docosahexaenoic acid (DHA) levels in extremely low birth weight (ELBW) infants.

详细描述

This will be a multi-center, randomized, placebo controlled, double blind trial.

Two doses of PUFA will be compared to placebo- a "high" dose and a "low" dose.

ELBW infants will be enrolled into this study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
— 至 72 Hours(Child)
性别
All
接受健康志愿者

入选标准

  • a) Premature infant born at gestational age less than 34 weeks
  • b) Birth weight less than 1000 grams
  • c) Legally authorized representative is able to provide written informed consent within the first 72 hours of life, prior to the performance of an protocol-specified evaluations or procedures

排除标准

  • a) infants with known metabolic disorder
  • b) infants with known congenital gastrointestinal anomaly
  • c) infants who are deemed to be inappropriate for enrollment per attending neonatologist

结局指标

主要结局

Long-chain Polyunsaturated Fatty Acid (LCPUFA) Levels

时间窗: 2 weeks of life

LCPUFA levels will be measured at 2 weeks of life in extremely low birth weight (ELBW) infants

次要结局

  • LCPUFA Levels(8 weeks of life)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Brandy Frost

Attending Neonatologist, Clinician Educator

Endeavor Health

研究点 (6)

Loading locations...

相似试验